Intertumoral Heterogeneity within Medulloblastoma Subgroups

Cavalli, Florence M.G., Remke, Marc, Rampasek, Ladislav, Peacock, John, Shih, David J.H., Luu, Betty, Garzia, Livia, Torchia, Jonathon +87 more·2017·Cancer Cell
DOI 10.1016/j.ccell.2017.05.005

Cited by (1,000)

Items 701–800 of 1,000

  1. Genomic tumor evolution dictates human medulloblastoma progression
    Yana Ruchiy, Ιωάννα Τσέα, Efthalia Preka, Bronte Manouk Verhoeven, Thale Kristin Olsen, Shenglin Mei, Indranil Sinha, Klas Blomgren, Lena-Maria Carlson, Cecilia H. Dyberg et al. · 2024 · Neuro-Oncology Advances
  2. 3D genome topology distinguishes molecular subgroups of medulloblastoma
    John J. Y. Lee, Michael J.G. Johnston, Hamza Farooq, Huey‐Miin Chen, Subhi Talal Younes, Raúl A. Suárez, Melissa Zwaig, Nikoleta Juretic, William A. Weiss, Jiannis Ragoussis et al. · 2024 · The American Journal of Human Genetics
  3. Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context
    Alexandre Gries, Karthiga Santhana Kumar, Fabien Kuttler, Özgün Özalp, Verónica Akle, Hanqing Zhang, Michael Andreas Grotzer, Stephan C. F. Neuhauss, Amin Allalou, Martin Baumgartner · 2024 · Neoplasia
  4. MYC promotes group 3 medulloblastoma cell proliferation and alleviates ROS-induced cell death by upregulating transketolase
    Shizun Wang, Dan Zhang, Chunlong Wang, Yuqin Liu · 2025 · Acta Neuropathologica Communications
  5. Medulloblastoma: biology and immunotherapy
    Alessandro Poggi, F. Reggiani, H. Azevedo, Lizzia Raffaghello, R. C. Pereira · 2025 · Frontiers in Immunology
  6. Study Protocol for HeartMagic: A Prospective Observational Cohort Characterizing Subtypes of Heart Failure With Preserved Ejection Fraction
    Philippe Meyer, Angela Rocca, Jaume Banús, Augustin C.C. Ogier, Costa Georgantas, Pauline Calarnou, Anam Fatima, Jean‐Paul Vallée, Jean‐François Deux, Aurélien Thomas et al. · 2025 · Journal of the American Heart Association
  7. Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain Tumors
    Somak Roy, Sameer Agnihotri, Soufiane El Hallani, Wayne L. Ernst, Abigail I. Wald, Lucas Santana‐Santos, Ronald L. Hamilton, Craig Horbinski, Nitin R. Wadhwani, Donald E. Born et al. · 2019 · Journal of Neuropathology & Experimental Neurology
  8. YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells
    Gustavo Alencastro Veiga Cruzeiro, Taciani de Almeida Magalhães, Graziella Ribeiro de Sousa, Ricardo Bonfim-Silva, Carlos Alberto Oliveira de Biagi, Pablo Shimaoka Chagas, Rosane Gomes de Paula Queiróz, Carlos Alberto Scrideli, Luíz Gonzaga Tone, Elvis Terci Valera · 2021 · Cancers
  9. Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification
    Hee Won Cho, Hyunwoo Lee, Hee Young Ju, Keon Hee Yoo, Hong Hoe Koo, Do Hoon Lim, Ki Woong Sung, Hyung Jin Shin, Yeon‐Lim Suh, Ji Won Lee · 2022 · Journal of Korean Medical Science
  10. ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma
    Lívia Fratini, Matheus Dalmolin, Marialva Sinigaglia, Alexandre da Silveira Perla, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Andre Tessainer Brunetto, Mariane da Cunha Jaeger, Rafael Roesler · 2022 · NeuroMolecular Medicine
  11. Delta-catenin attenuates medulloblastoma cell invasion by targeting EMT pathway
    Yuanjun Hu, Sihan Zhu, Ri-zhen Xu, Manxia Wang, Furong Chen, Zeshun Zhang, Binghong Feng, Jian Wang, Zhongping Chen, Jing Wang · 2022 · Frontiers in Genetics
  12. Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas
    Manon Penco-Campillo, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi‐Boncompagni, Vincent Picco, Maeva Dufies, Cyril Ronco, Rachid Benhida et al. · 2022 · Cells
  13. Identification of CD114 Membrane Receptors as a Molecular Target in Medulloblastomas
    Jander Moreira Monteiro, Jaqueline Isadora Reis Ramos, Ian Teixeira e Sousa, Rayana Longo Bighetti‐Trevisan, Jurandir Marcondes Ribas-Filho, Gustavo Rassier Isolan · 2023 · International Journal of Molecular Sciences
  14. Current Open Trials and Molecular Update for Pediatric Embryonal Tumors
    Tom Rosenberg, Tabitha M. Cooney · 2023 · Pediatric Neurosurgery
  15. Clinico-Radiological Outcomes in WNT-Subgroup Medulloblastoma
    Shakthivel Mani, Abhishek Chatterjee, Archya Dasgupta, Neelam Vishwanath Shirsat, Akash Pawar, Sridhar Epari, Ayushi Sahay, Arpita Sahu, Aliasgar V. Moiyadi, Maya Prasad et al. · 2024 · Diagnostics
  16. Risk-stratification for treatment de-intensification in WNT-pathway medulloblastoma: finding the optimal balance between survival and quality of survivorship
    Tejpal Gupta, Shakthivel Mani, Abhishek Chatterjee, Archya Dasgupta, Sridhar Epari, Girish Chinnaswamy · 2024 · Expert Review of Anticancer Therapy
  17. Medulloblastoma: Molecular Targets and Innovative Theranostic Approaches
    Alice Foti, Fabio Allia, Marilena Briglia, Roberta Malaguarnera, Gianpiero Tamburrini, Francesco Cecconi, Vittoria Pagliarini, Francesca Nazio, Adriana Carol Eleonora Graziano · 2025 · Pharmaceutics
  18. Pediatric medulloblastoma in the molecular era: what are the surgical implications?
    Michelle Masayo Kameda-Smith · 2020 · Cancer and Metastasis Reviews
  19. Embryonal tumors of the central nervous system
    Mélanie Pagès, Julien Masliah‐Planchon, Franck Bourdeaut · 2020 · Current Opinion in Oncology
  20. Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes
    Jinyi Chen, Zhuang Kang, Shenglan Li, Can Wang, Xiaohong Zheng, Zehao Cai, Lexin Pan, Feng Chen, Wenbin Li · 2022 · Frontiers in Immunology
  21. Research progress in molecular pathology markers in medulloblastoma
    Zixuan Zhou, Bingxin Zhu, Qingming Meng, Tong Zhang, Yihao Wu, Rutong Yu, Shangfeng Gao · 2023 · Exploration of Targeted Anti-tumor Therapy
  22. Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma
    Dheeraj Chinnam, Aastha Saraswati, Swathi Jogunoori, Aanchal Verma, Tanvi Kiran, Pravin Salunke, Nalini Gupta, Narendra Kumar, Renu Madan, Bishan Dass Radotra et al. · 2023 · Applied immunohistochemistry & molecular morphology
  23. Mitochondrial subtype MB-G3 contains potential novel biomarkers and therapeutic targets associated with prognosis of medulloblastoma
    Qiang Li, Yanfei Jia, Bo Tang, Hu Yang, Qiang Yang, Xiaodong Luo, Yawen Pan · 2023 · Biomarkers
  24. Differential Expression of Mitochondrial Biogenesis Markers in Mouse and Human SHH-Subtype Medulloblastoma
    Maria Łastowska, Agnieszka Karkucińska‐Więckowska, James A. Waschek, Paweł Niewiadomski · 2019 · Cells
  25. Histone deacetylase inhibitors induce medulloblastoma cell death independent of HDACs recruited in REST repression complexes
    Abdulelah Saleh Alshawli, Heiko Wurdak, Ian C. Wood, John Edward Ladbury · 2020 · Molecular Genetics & Genomic Medicine
  26. Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets
    Ed C. Schwalbe, H. Lalchungnunga, Fadhel Mohammed Lafta, Timothy M. Barrow, Gordon R. Strathdee · 2021 · Oncogene
  27. Dynamic profiling of medulloblastoma surfaceome
    David Bakhshinyan, Yujin Suk, Laura Kuhlmann, Ashley Adile, Vladimir Ignatchenko, Stefan Custers, William D. Gwynne, Andrew M. Macklin, Chitra Venugopal, Thomas Kislinger et al. · 2023 · Acta Neuropathologica Communications
  28. Using evolutionary constraint to define novel candidate driver genes in medulloblastoma
    Ananya Roy, Sharadha Sakthikumar, Sergey V. Kozyrev, Jessika Nordin, Raphaela Pensch, Suvi Mäkeläinen, Mats E. Pettersson, Elinor K. Karlsson, Kerstin Lindblad‐Toh, Karin Forsberg‐Nilsson et al. · 2023 · Proceedings of the National Academy of Sciences
  29. Patient Similarity Network of Multiple Myeloma Identifies Patient Sub-groups with Distinct Genetic and Clinical Features
    Sherry Bhalla, David T. Melnekoff, Jonathan J. Keats, Kenan Onel, Deepu Madduri, Joshua Ryan Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Joel T. Dudley et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  30. PTEN restrains SHH medulloblastoma growth through cell autonomous and nonautonomous mechanisms
    Zhimin Lao, Salsabiel El Nagar, Yinwen Liang, Daniel N. Stephen, Alexandra L. Joyner · 2025 · eLife
  31. Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis
    Yuichi Mitani, Kohei Fukuoka, Makiko Mori, Yuki Arakawa, Yuko Matsushita, Yuko Hibiya, Satoko Honda, Masao Kobayashi, Yutaka Tanami, Yonehiro Kanemura et al. · 2020 · Journal of Neuropathology & Experimental Neurology
  32. Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis
    Boang Han, Yu Wang, Shen Yue, Yun-hao Zhang, Lun Kuang, Binbin Gao, Yue Wang, Ziyu Zhang, Xiaohong Pu, Xin-fa Wang et al. · 2024 · JCI Insight
  33. Single‐Cell Chromatin Accessibility Analysis Reveals Subgroup‐Specific TF‐NTR Regulatory Circuits in Medulloblastoma
    Xiaoyue Gao, Qiyuan Zhuang, Yun Li, Guochao Li, Zheng Huang, Shenzhi Chen, Shaoxing Sun, Hui Yang, Lan Jiang, Ying Qing Mao · 2024 · Advanced Science
  34. Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies
    Marthe Sönksen, Denise Obrecht, Pablo Hernáiz Driever, Axel Sauerbrey, Norbert M. Graf, Udo Kontny, Christian Reimann, Mina Langhein, Uwe Kordes, Rudolf Schwarz et al. · 2024 · Neuro-Oncology
  35. Human stem cell models to unravel brain cancer
    Biren M. Dave, Jignesh K. Tailor · 2024 · BMC Cancer
  36. Comparative analysis of pediatric SHH medulloblastoma DAOY spheres and adherent monolayers: implications for medulloblastoma research
    Jana Klementová, Šárka Jarošová, Irina Danilová, Markéta Farníková, Josef Novotný, Marie Davídková, Martina Zı́ková · 2025 · Cancer Cell International
  37. Unveiling spatial heterogeneity in medulloblastoma: A multi-omics analysis of cellular state and geographical organization
    Jiankang Li, Hailong Liu, Ziwei Wang, Jiao Zhang, Xuan Chen, Craig E Daniels, Xiaochong Wu, Olivier Saulnier, Hiromichi Suzuki, Pasqualino De Antonellis et al. · 2025 · Neuro-Oncology
  38. The transcription factor LHX2 mediates and enhances oncogenic BMP signaling in medulloblastoma
    Yae Ohata, Mohamad Moustafa Ali, Yutaro Tsubakihara, Yuka Itoh, Gabriela Rosén, Tobias Bergström, Anita Morén, Irene Golán Cancela, Ayana Nakada, Oleksandr Voytyuk et al. · 2025 · Cell Death and Differentiation
  39. MYCN as an oncogene in pediatric brain tumors
    Adriana Fernandez Garcia, Jayden Jackson, Poorvi Iyer, Elissa G. Oliver, Kosuke Funato · 2025 · Frontiers in Oncology
  40. Aberrant histone modifications in pediatric brain tumors
    Erin T. Hamanishi, Derek Dang, Sriram Venneti · 2025 · Frontiers in Oncology
  41. Challenges and Innovations in Paediatric Brain Tumour Treatments
    Nadia Shah, Jessica Sohl, Massimo Ganassi, Loredana Guglielmi, Sara Badodi · 2025 · Pharmaceutics
  42. Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma
    Dong Wang, Caitlin Ritz, Yuhuan Luo, Ammu Suresh, Angela M. Pierce, Bethany L. Veo, Breauna Brunt, Nathan A. Dahl, Natalie Julie Serkova, Sujatha Venkataraman et al. · 2025 · Nature Communications
  43. Médulloblastome. Anatomie pathologique
    Aurore Siegfried, Marie‐Bernadette Delisle · 2018 · Neurochirurgie
  44. Exploring the role and clinical implications of proteasome inhibition in medulloblastoma
    Clay Hoerig, Ashley Plant, Michelle D. Pulley, Kaijun Di, Daniela Annenelie Bota · 2021 · Pediatric Blood & Cancer
  45. Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma
    Satarupa Sengupta, Shiva Senthil Kumar, Kathryn M. Bondra, Matthew Sobo, Xiaokui Molly Mo, Rachid Drissi · 2023 · Frontiers in Oncology
  46. Infratentorielle Hirntumoren bei Kindern
    Johanna Lieb, A. Lonak, A. Vogler, Friederike Prüfer, Frank Johannes Ahlhelm · 2023 · Die Radiologie
  47. WNT‐activated, MYC ‐amplified medulloblastoma displaying intratumoural heterogeneity
    Sage T. Green, Travis Hoover, David Doss, Kimberly Ann Davidow, Andrew W. Walter, Catherine E. Cottrell, Sidharth Mahapatra · 2023 · Neuropathology and Applied Neurobiology
  48. The Role of Circular RNA Variants Generated from the NFIX Gene in Different Diseases
    Lei Zhang, Xin Li, Huijuan Gao, Peifeng Li · 2024 · Molecular Pharmaceutics
  49. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules
    Francesca Bibbò, Fatemeh Asadzadeh, Angelo Sabato Boccia, Carmen Sorice, Orazio Bianco, Carmen Daniela Saccà, Barbara Majello, Vittoria Donofrio, Delfina Bifano, Lucia De Martino et al. · 2024 · International Journal of Molecular Sciences
  50. Pediatric central nervous system tumor with CIC::LEUTX fusion: a diagnostic challenge
    Yanghao Hou, Yanru Du, Juan Wang, Xinke Zhang, Xueyan Zhao, Xinyi Xian, Yuan Li, Haigang Li, Yu Wang, Shaoyan Xi et al. · 2024 · Acta Neuropathologica Communications
  51. Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
    Changlin Yang, Vrunda S. Trivedi, Kyle A. Dyson, Tongjun Gu, Kate M. Candelario, Oleg Yegorov, Duane A. Mitchell · 2024 · Genome Medicine
  52. Treatment of Medulloblastoma in the Adolescent and Young Adult Population: A Systematic Review
    Maria Otth, Annette Weiser, Seok-Yun Lee, Lukas Rudolf von Rohr, Philip Heesen, Ana Guerreiro Stücklin, Katrin Scheinemann · 2024 · Journal of Adolescent and Young Adult Oncology
  53. Application of radiomics for diagnosis, subtyping, and prognostication of medulloblastomas: a systematic review
    Maryam Fotouhi, Ataollah Shahbandi, Fardin Samadi Khoshe Mehr, Mahdi Mohammadzadeh Shahla, Seyed Mobin Nouredini, Samuel Berchi Kankam, MirHojjat Khorasanizadeh, Lola Blackwell Chambless · 2024 · Neurosurgical Review
  54. The pivotal role of autophagy in the pathogenesis and therapy of medulloblastoma
    Seidu A. Richard · 2024 · Future Oncology
  55. Nanopore sequencing as a cutting-edge technology for medulloblastoma classification
    Mathilde Filser, Jacob Torrejon-Diaz, Kevin Merchadou, Christelle Dufour, Elodie Girard, Christine Bourneix, Elisa Lemaître, Tarek Gharsalli, Riwan Brillet, Jennifer Wong et al. · 2024 · Neuro-Oncology
  56. Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres
    Natália Hogetop Freire, Alice Laschuk Herlinger, Júlia Vanini, Matheus Dalmolin, Marcelo A. C. Fernandes, Carolina Nör, Vijay Ramaswamy, Caroline Brunetto de Farias, Andre Tesainer Brunetto, Algemir Lunardi Brunetto et al. · 2025 · Cells
  57. Immunomodulatory role of exosome-derived content in pediatric medulloblastoma: a molecular subgroup perspective
    Jessica Oliveira de Santis, Graziella Ribeiro de Sousa, Rosane Gomes de Paula Queiróz, Marina Ferreira Cândido, Fausto Bruno dos Reis Almeida, Caroline Patini Rezende, Patrícia de Cássia Ruy, Gabriel Santos Arini, Beth Coyle, Philippa Wade et al. · 2025 · Human Cell
  58. Enhanced plasma and brain concentrations and medulloblastoma cytotoxicity of asciminib and nilotinib by P-glycoprotein inhibition with tariquidar
    Eric M. Thompson, Lin Cheng, Ivan Spasojević · 2025 · Anti-Cancer Drugs
  59. Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression
    Wan-Chen Wang, Kohei Kumegawa, Owen S. Chapman, Ryo Shiraishi, Zhize Xiao, Konstantin Okonechnikov, Yang Sun, Stefan Michael Pfister, Weijun Feng, Naofumi Uesaka et al. · 2025 · Cell Reports
  60. Disruption of rack1 suppresses SHH‐type medulloblastoma formation in mice
    Fengjiao Liu, Jingyuan Shao, Haihong Yang, Guochao Yang, Qian Zhu, Yan Wu, Lingling Zhu, Haitao Wu · 2021 · CNS Neuroscience & Therapeutics
  61. Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies
    Abhishek Chatterjee, Madan Maitre, Archya Dasgupta, Sridhar Epari, Tejpal Gupta · 2022 · Methods in molecular biology
  62. Integration of immunohistochemistry, RNA sequencing, and multiplex ligation‐dependent probe amplification for molecular classification of pediatric medulloblastoma
    Hsin‐Yi Huang, Chih‐Hsiang Yu, Yung‐Li Yang, Ya‐Hsuan Chang, Shiann‐Tarng Jou, Kai‐Hsin Lin, Meng‐Yao Lu, Hsiu‐Hao Chang, Shu‐Wei Chou, Yu‐Ling Ni et al. · 2022 · Pediatric Blood & Cancer
  63. Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies
    Christopher Montemagno, Frédéric Luciano, Gilles Pagès · 2022 · Methods in molecular biology
  64. Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells
    Pablo Shimaoka Chagas, Luciana Chain Veronez, Graziella Ribeiro de Sousa, Gustavo Alencastro Veiga Cruzeiro, Carolina Alves Pereira Corrêa, Fabiano Pinto Saggioro, Rosane Gomes de Paula Queiróz, Suely Kazue Nagahashi Marie, Sílvia Regina Brandalise, Izilda Aparecida Cardinalli et al. · 2023 · Human Cell
  65. Linked-read based analysis of the medulloblastoma genome
    Melissa Zwaig, Michael J.G. Johnston, John J. Y. Lee, Hamza Farooq, Marco Gallo, Nada Jabado, Michael D. Taylor, Jiannis Ragoussis · 2023 · Frontiers in Oncology
  66. Neurodegeneration-associated protein VAPB regulates proliferation in medulloblastoma
    Amanda F. Assoni, Thiago Mitsugi, René Wardenaar, Raiane Oliveira Ferreira, Elisa Helena Farias Jandrey, Gabriela Machado Novaes, Isabela Fonseca de Oliveira Granha, Petra L. Bakker, Carolini Kaid, Mayana Zatz et al. · 2023 · Scientific Reports
  67. CTGF expression is indicative of better survival rates in patients with medulloblastoma
    Gustavo Alencastro Veiga Cruzeiro, Régia Caroline Peixoto Lira, Taciani de Almeida Magalhães, Carlos Alberto Scrideli, Elvis Terci Valera, Martin Baumgartner, Luíz Gonzaga Tone · 2019 · Cancer Gene Therapy
  68. Abnormal spindle-like microcephaly-associated (ASPM) gene expression in posterior fossa brain tumors of childhood and adolescence
    Débora Cabral de Carvalho Corrêa, Indhira Dias Oliveira, Bruna Mascaro-Cordeiro, Frederico Adolfo Silva, Maria Teresa de Seixas Alves, Nasjla Saba‐Silva, Andréa Maria Capellano, Patrícia Alessandra Dastoli, Sérgio Cavalheiro, Sílvia Regina Caminada de Toledo · 2020 · Child s Nervous System
  69. ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression
    Annika Dwucet, Maximilian Pruss, Qiyu Cao, Mine Tanriover, Varun V. Prabhu, Joshua E. Allen, Aurelia Peraud, Mike‐Andrew Westhoff, Markus David Siegelin, Christian Rainer Wirtz et al. · 2021 · Frontiers in Cell and Developmental Biology
  70. The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma
    Mirella Baroni, Gabriela D. A. Guardia, Xiufen Lei, Adam Kosti, Mei Qiao, Tesha Landry, Karl Mau, Pedro A. F. Galante, Luiz O. F. Penalva · 2021 · Cells
  71. The Architecture of a Precision Oncology Platform
    Alessandro Laganà · 2022 · Advances in experimental medicine and biology
  72. Recent Advancement of the Molecular Diagnosis in Pediatric Brain Tumor
    Jeongmo Bae, Jae‐Kyung Won, Sung‐Hye Park · 2018 · Journal of Korean Neurosurgical Society
  73. Taxonomy of CNS tumours; a series of three short reviews on the WHO 2016 classification and beyond
    Pieter Wesseling, Thomas S. Jacques · 2017 · Neuropathology and Applied Neurobiology
  74. A minimally guided organoid model for cross-species comparisons of cerebellar development
    Luca Guglielmi, Daniel J Lloyd-Davies Sanchez, José González‐Martínez, Madeline A. Lancaster · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Supplementary Prompt Learning for Vision-Language Models
    Rongfei Zeng, Zhipeng Yang, Ruiyun Yu, Yonggang Zhang · 2025 · International Journal of Computer Vision
  76. Multimodal Validation of the Existence of Transitional Cerebellar Progenitors in the Human Fetal Cerebellum
    Zaili Luo, Mingyang Xia, Feng Zhang, Dazhuan Eric Xin, Rohit Rao, Karrie Mei Yee Kiang, Kalen Berry, Yu Xiong, Hongqi Liu, Yifeng Lin et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  77. High cellular plasticity state of medulloblastoma local recurrence and distant dissemination
    Hailong Liu, Jing Zhang, Ziwei Wang, Wei Wang, Dongming Han, Xuan Chen, Yu Su, Jiao Zhang, Craig E Daniels, Olivier Saulnier et al. · 2025 · Cell Reports Medicine
  78. Medulloblastoma in Adolescents and Young Adults (AYA): Bridging Pediatric Paradigms and Adult Oncology Practice
    Antonio Ruggiero, Giorgio Attinà, Dario Talloa, Stefano Mastrangelo, Alberto Romano, Palma Maurizi, Silvia Chiesa, Gianpiero Tamburrini, Alessandro Olivi, Alessio Albanese · 2025 · Journal of Clinical Medicine
  79. Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors
    Rebecca R. J. Collins, Rebecca R. Florke Gee, Sima Tozandehjani, Tara Bayat, Maria Camila Hoyos Sanchez, Juan Sebastian Solano Gutierrez, Barbara Breznik, Anna K. Lee, Sam Peters, Jon P. Connelly et al. · 2025 · Acta Neuropathologica Communications
  80. Opposite patterns of association of TWIST1 expression with patient survival in SHH and Group 4 medulloblastoma
    Karina Munhoz de Paula Alves Coelho, Matheus Dalmolin, Francis Rossetti Pedack, José Guilherme Jasper Pickler, Camila Barbosa, Julio Recalde, Rodrigo Blasius, Bruna Louise Silva, Marcelo A. C. Fernandes, Hercílio Fronza et al. · 2025 · Child s Nervous System
  81. Image-Based Deep Learning for Brain Tumour Transcriptomics: A Benchmark of DeepInsight, Fotomics, and Saliency-Guided CNNs
    Ali Alyatimi, Yuk Ying Chung, Muhammad Atif Iqbal, Ali Anaissi · 2025 · Machine Learning and Knowledge Extraction
  82. Late Effects in Survivors of Pediatric Medulloblastoma: A Comprehensive Review
    Ana Carolina Izurieta‐Pacheco, Vijay Ramaswamy, Derek S. Tsang, James T. Rutka, Jonathan Daniel Wasserman, Sharon Guger, Danielle R. Weidman, Paul Craig Nathan, Katrin Scheinemann, Julie Bennett · 2025 · Pediatric Blood & Cancer
  83. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment
    Arthur Karaulic, Clémence Fournier, Gilles Pagès · 2025 · Cancers
  84. Strategies for the Molecular Classification of Medulloblastoma
    Josselen Carina Ramírez‐Chiquito, Sergio Juárez‐Méndez · 2025 · Biomedicines
  85. Medulloblastoma stem cell programs: Molecular roadmaps of disease progression
    Jamie L. Zagozewski, Parthiv Haldipur, Kathleen J. Millen, Tamra E. Werbowetski‐Ogilvie · 2025 · Developmental Cell
  86. Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer
    Xuan Chen, Ziwei Wang, Yan Song, Yu Su, Yahui Zhao, Jiankang Li, Wei Wang, Jiao Zhang, Craig Daniels, Xiaochong Wu et al. · 2025 · Cell Reports Medicine
  87. A functionally relevant model for interrogating brain tumor-endothelial cell interactions
    Akaljot Grewal, Emma Martell, Helgi Kuzmychova, Ujala Chawla, Charul Jain, Kayshana Ramnauth, Tanveer Sharif · 2025 · Journal of Neuroscience Methods
  88. Identification of Raptor and GLI1 as USP37 substrates highlight its context-specific function in medulloblastoma cells
    Ashutosh Kumar Singh, Donghang Cheng, Amanda R. Haltom, Yanwen Yang, Tara Dobson, Rashieda J. Hatcher, Veena Rajaram, Vidya Gopalakrishnan · 2025 · Oncogene
  89. MIF-CD74 signaling drives immune modulation in medulloblastoma
    Benjamin Draper, Zhen You, Dean Thompson, Xu Guo, Alaide Morcavallo, Diego Chillón Pino, Carlos Lorenzo Gido Nery, Sumana Shrestha, Chantelle E Bowers, Courtney Himsworth et al. · 2026 · Neuro-Oncology
  90. Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study
    Stacey Richardson, Debbie Hicks, Melissa Gough, Ellie R. Butler, Dean Thompson, Jemma Castle, Stephen Crosier, Miguel García-Ariza, Idoia Martín‐Guerrero, Sabine L. A. Plasschaert et al. · 2026 · The Lancet Child & Adolescent Health
  91. Seltene Tumordispositionssyndrome mit Manifestation im Kindesalter
    Tim Ripperger, Katharina Wimmer, Christian Peter Kratz · 2017 · Medizinische Genetik
  92. Somatic mutational profiling and clinical impact of driver genes in Latin‐Iberian medulloblastomas: Towards precision medicine
    Letícia Ganem Rillo Paz Barateiro, Rodrigo de Oliveira Cavagna, Mariana Bisarro dos Reis, Flávia Escremim de Paula, Gustavo Ramos Teixeira, Daniel Antunes Moreno, Murilo Bonatelli, Iara Viana Vidigal Santana, Fabiano Pinto Saggioro, Luciano Neder et al. · 2024 · Neuropathology
  93. PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastoma
    Nazia Nazam, Michael H. Erwin, Janet Rae Julson, Colin H. Quinn, Andee M. Beierle, Laura V. Bownes, Jerry E. Stewart, Kyung‐Don Kang, Swatika P. Butey, Elizabeth Mroczek‐Musulman et al. · 2024 · Journal of Biological Chemistry
  94. AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype
    Julie Sesen, Tyra Martinez, Sara Busatto, Larysa Poluben, Hassan Nassour, Caroline E. Stone, Karthik Ashok, Marsha A. Moses, Edward R. Smith, Aram Ghalali · 2025 · Journal of Experimental & Clinical Cancer Research
  95. miR-512-3p as a Potential Biomarker of Poor Outcome in Pediatric Medulloblastoma
    Carolina Alves Pereira Corrêa, Pablo Shimaoka Chagas, Mirella Baroni, Augusto Faria Andrade, Rosane Gomes de Paula Queiróz, Veridiana Kiill Suazo, Gustavo Alencastro Veiga Cruzeiro, Paola Fernanda Fedatto, David Santos Marco Antônio, Sílvia Regina Brandalise et al. · 2025 · The Cerebellum
  96. Multi-omics analysis reveals key immunogenic signatures induced by oncolytic Zika virus infection of paediatric brain tumour cells
    Matt Sherwood, Thiago Mitsugi, Carolini Kaid, Brandon Coke, Mayana Zatz, Kevin Maringer, Oswaldo Keith Okamoto, Rob M. Ewing · 2025 · Scientific Reports
  97. Medulloblastoma’s master regulators and their association with patients’ risk
    Gustavo Lovatto Michaelsen, Tayrone de Sousa Monteiro, Danilo Oliveira Imparato, João Vitor Almeida da Costa, Daniel Rocha Silva, Iara Dantas de Souza, Marcel da Câmara Ribeiro-Dantas, Otávio Cabral-Marques, Marialva Sinigaglia, Rodrigo Juliani Siqueira Dalmolin · 2025 · Scientific Reports
  98. Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencing
    Dean Thompson, Jemma Castle, Martin Sill, Stefan Michael Pfister, Simon Bailey, Debbie Hicks, Steven C. Clifford, Ed C. Schwalbe · 2025 · Acta Neuropathologica Communications
  99. The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma
    Laura Hruby, Katerina Schaal, Alberto Delaidelli, Daniel J. Picard, Christopher P. Dunham, Oksana Lewandowska, Tobias Reiff, Magalie Larcher, Célio Pouponnot, Poul H. B. Sorensen et al. · 2025 · Cell Death Discovery
  100. In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients
    Anna M. Jermakowicz, Luz Clarita Ruiz, Jonathan Chu, Nitish Jangde, Robert K. Suter, Nina S. Kadan‐Lottick, Derek J. Hanson, Nagi G. Ayad · 2025 · Scientific Reports